logo-loader
NASDAQ:ABOS

Acumen Pharmaceuticals Inc.

Receive alerts
Market:
NASDAQ
Price
0.19 USD
Day Change
-15.52%
Market Cap:
$14.06 m
52 weeks high
3.60
52 weeks low
0.19

In brief

Acumen Pharmaceuticals develops treatments for Alzheimer's disease. Its clinical pipeline includes sabirnetug, an investigational antibody targeting soluble amyloid beta oligomers.